Advertisement

Immunmodulation der antigeninduzierten Arthritis der Maus

  • D. Brackertz
Conference paper
Part of the Der Rheumatismus book series (2798, volume 45)

Zusammenfassung

Für viele menschliche Immunopathien, insbesondere für die entzündlichen rheumatischen Erkrankungen, ist die Ätiopathogenese noch weitgehend ungeklärt. Tiermodelle, die Merkmale menschlicher Erkrankungen aufweisen, tragen daher unter Umständen entscheidend zum besseren Verständnis der pathogenetisch wirksamen Mechanismen dieser Krankheitsbilder bei. Solche Modelle haben den Vorteil, daß sie sich häufig optimal definieren lassen und eignen sich zudem vorzüglich zur Erprobung von modulierenden Substanzen und Faktoren der Entzündung bzw. der Immunantwort.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Cole BC, Washburn LR, Samuelson CO, Ward JR (1982) Experimental models of rheumatoid arthritis systemic lupus erythematosus and scleroderma. In: Panayi G (Hrsg) Scientific Basis of Rheumatology. Churchill Livingstone, p 22Google Scholar
  2. 2.
    Drew RA (1972) Erisipelothrix arthritis in pigs as a comparative model for rheumatoid arthritis. Proc R Soc Med 65:42Google Scholar
  3. 3.
    Volkman A, Collins FW (1973) Polyarthritis associated with Salmonella infection in rats. Infect Immun 8:814PubMedGoogle Scholar
  4. 4.
    Taylor-Robinson D, Taylor G (1976) Do mycoplasmas cause rheumatic disease? In: Dumonde D (Hrsg) Infection and Immunology in the Rheumatic Diseases. Blackwell Scientific Publications Oxford, p 177Google Scholar
  5. 5.
    Olson NO, Kerr KM (1966) Some characteristics of an avian arthritis viral agent. Avian Dis 10:470PubMedCrossRefGoogle Scholar
  6. 6.
    Stoerk HC, Bielinski TC, Budzilovich T (1954) Chronic polyarthritis in rats injected with spleen in adjuvants. Amer J Pathol 30:616 (Abstr.)Google Scholar
  7. 7.
    Dumonde DC, Glynn LE (1962) The production of arthritis in rabbits by an immunological reaction to fibrin. Br J Exp Pathol 43:373PubMedGoogle Scholar
  8. 8.
    Trentham DE, Townes AS, Kang AH (1977) Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 146:857PubMedCrossRefGoogle Scholar
  9. 9.
    Brackertz D, Mitchell GF, Mackay JR (1977 a) Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice. Arthritis Rheum 20:841PubMedCrossRefGoogle Scholar
  10. 10.
    Brackertz D, Mirchell GF, Vadas MA, Mackay JR, Miller JAFP (1977 b) Studies of antigen-induced arthritis in mice. II. Immunologic correlates of arthritis susceptibility in mice. J Immunol 118:1639PubMedGoogle Scholar
  11. 11.
    Brackertz D, Mitchell GF, Vadas MA, Mackay JR (1977 c) Studies on antigen-induced arthritis in mice. III. Cell and serum transfer experiments. J Immunol 118:1645PubMedGoogle Scholar
  12. 12.
    Schuermanns Y (1975) Levamisole in rheumatoid arthritis. Lancet 1:111CrossRefGoogle Scholar
  13. 13.
    Huskisson EC, Scott J, Balme HW, Dieppe PA, Traphelli J, Willoughby DA (1976) Im-mostimulant therapy with levamisole for rheumatoid arthritis. Lancet 1:393PubMedCrossRefGoogle Scholar
  14. 14.
    Wybran H, Govaerts A (1977) Levamisole and human lymphocyte surface markers. Chin Exp Immunol 27:319Google Scholar
  15. 15.
    Michalevicz R, Many A, Ramot B, Trainin N (1978) The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients. Clin Exp Immunol 31:111PubMedGoogle Scholar
  16. 16.
    Nogueira Machada JA, Jones Antunes L, Novato Silva E (1977) E-rosette formation in “active” T-lymphocytes; phenomenon modulated by the intracellular level of cyclic AMP and GMP. Rev Bras Pesqui Med Biol 10(4):241Google Scholar
  17. 17.
    DiPerri T, Auteri A, Laghini Pasini L, Mattioloi F, Volpi L (1979) Action of levamisole on the E-rosette forming cells and serum adenosine deaminase in Hodgkin’s disease. J Immunopharmacol 1(2)233–246CrossRefGoogle Scholar
  18. 18.
    Sushine G, Lopez-Corrales E, Hadden M, Coffey RG, Wanebo H, Hadden JW, Rojas A (1977) Levamisole and imidazole; in vitro effects in mouse and man and their possible mediation by cyclic nucleotides. In: Chirigos MA (ed) Modulation of host immune resistance in the prevention or treatment of induced neoplasias. 31, Forgatery International Center Proceedings No. 28 Washington: U.S. Government Printing OfficeGoogle Scholar
  19. 19.
    Padarathsingh ML, Dean JH, McCoy JL, Lewis DD, Morthing JW (1978) Restorative effects of levamisole on cellmediated immune responses following chemotherapy with anilin mustard in mice bearing adj-pcs plasmocytoma. Unpublished report, May 1978Google Scholar
  20. 20.
    Hadden JW, Englard A, Sadlik JR, Hadden EM (1978) The comparative effects of isoprinosine, levamisole, murayml dipeptide and SM 1213 on lymphocyte and macrophage proliferation and activation in vitro. Unpublished report, June 1978Google Scholar
  21. 21.
    Ceglowski WS (1977) Effects of immunoactive substances on murine virus leukemogenesis and immunosuppression. In: Chirigos MA (ed) Modulation of host immune resistance in the prevention or treatment of induced neoplasias. 287. Forgarty International Center Proceedings No. 28, Washington: U.S. Government Printing OfficeGoogle Scholar
  22. 22.
    Renoux G, Renoux M (1977) Roles of the imidazole or thiol moiety on the immunostimulant action of levamisole. In: Chirigos MA (ed) Control of neoplasia by modulation of the immune system. Raven Press, New York, p 67Google Scholar
  23. 23.
    Renoux G, Renoux M (1977) Thymus-like activities of sulphur derivates on T-cell differentiation. J Exp Med 145:466PubMedCrossRefGoogle Scholar
  24. 24.
    Persico F, Potter WA (1978) The effect of levamisole on an in vitro model of cellular immunity. In: Chirigos MA (ed) Immune modulation and control of neoplasia by adjuvant therapy. Raven Press, New York, p 85Google Scholar
  25. 25.
    Nathanson SD, Zamfirescu PL, Dekernion J (1977) Acute changes in monocyte motility following oral levamisole (abstract). J Reticuloendothel Soc 22, suppl. 18AGoogle Scholar
  26. 26.
    Rabson AR, Anderson R, Glover A (1977) Defective neutrophil movement. In vitro and in vivo effects levamisole (abstract). Ann Allergy 38(4):308Google Scholar
  27. 27.
    Multicenter Study Group (1978) Levamisole in rheumatoid arthritis. A multicenter randomized double-blind study comparing two dosage schedules of levamisole and placebo. Lancet II: 1007Google Scholar
  28. 28.
    Urist MM, Boddie AW, Townsend CM, Holmes EC (1977) In vitro evidence for increased cellular immunity to lung cancer antigen during levamisole immunotherapy. J Throrac Cardiovasc Surg 73(2):189Google Scholar
  29. 29.
    Windil R, Wood RFM, Bell PFR (1978) Reduction of the duration of postoperative immunosuppression by levamisole. Br J Surg 65:355Google Scholar
  30. 30.
    Kazura J, Guerry D, Negendank W, Cooper RA, Schreiber AD (1977) Human monocyte-lym-phocyte interaction mediated by concanavalin A: the effect of levamisole. In: Lucas DO (ed) Regulatory mechanism in lymphocyte activation. New York, Academic Press, p 722Google Scholar
  31. 31.
    Molin L, Stendahl O (1977) Enhancing effect of levamisole one the phagocytic activity of human neutrophil polymorphonuclear leucocytes in vitro. Scand J Haematol 19:93PubMedCrossRefGoogle Scholar
  32. 32.
    Van Ginckel RF, Hoebeke J (1975) Carbon clearance enhancing factor in serum of levamisole treated mice. J Reticuloendothel Soc 17(2):65PubMedGoogle Scholar
  33. 33.
    Abad M, Chang S, Hokama Y (1976) The effect of levamisole spleen peroxisomal enzymes and DNA synthesis in rats of different age groups (Abstract). Vorgetragen auf dem Annual Xavier MBS-Biomedical Symposium Xavier University New Orleans, Louisiana, April 1976Google Scholar
  34. 34.
    Brackertz D, Hugentobler W, Müller W, Rossi R (1980) Levamisol: Modulation der zeilvermittelten Immunität vom verzögerten Typ sowie der Antigen-induzierten Arthritis bei Mäusen. Verh Dtsch Ges Rheumatol 6:109Google Scholar
  35. 35.
    Vadas MA, Miller JAFP, Gamble J, Whitelaw A (1975) A radioisotopic method to measure delayed type hypersensitivity in the mouse. I. Studies in sensitized and normal mice. Int Arch Allergy Appl Immunol 49:679CrossRefGoogle Scholar
  36. 36.
    Brackertz D, Mohr W, Fritsch R (1983) A radioisotopic method to measure the severity of antigen-induced arthritis in mice. Clin Rheumatol 2:86Google Scholar
  37. 37.
    Hench PS (1938) The ameliorating effect of pregnancy of chronic (atrophic infectious rheumatoid) arthritis, fibrosis and intermittent hydrathosis. Proc Mayo Clin 13:161Google Scholar
  38. 38.
    Bayles TB, Riddell CB (1944) Plasma lipids in patients with rheumatoid arthritis receiving gold salt therapy and during pregnancy. Ann J Med Sci 208:343CrossRefGoogle Scholar
  39. 39.
    Oka M (1953) Effect of pregnancy on the onset and course of rheumatoid arthritis. Ann Rheum Dis 2:227CrossRefGoogle Scholar
  40. 40.
    Smith WD, West HF (1960) Pregnancy and rheumatoid arthritis. Acta Rheum Scand 6:189CrossRefGoogle Scholar
  41. 41.
    Morris WJC (1969) Pregnancy in rheumatoid arthritis and systemic lupus erythematosus. Aust NZ J Obstet Gynaecol 9:136CrossRefGoogle Scholar
  42. 42.
    Neely NT, Persellin RH (1977) Activity of rheumatoid arthritis during pregnancy. Tex Med 73:59PubMedGoogle Scholar
  43. 43.
    Ostensen M, Aune B, Husby G (1983) Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand J Rheumatol 12:69PubMedCrossRefGoogle Scholar
  44. 44.
    Kawai T (1973) Clinical aspects of the plasmaproteins. Lippincott, PhiladelphiaGoogle Scholar
  45. 45.
    Lin TM, Halbert SP, Kiefer D, Spellacy WN, Gall S (1974) Characterisation of four human pregnancy-associated plasma proteins. Am J Obstet Gynecol 118:223PubMedGoogle Scholar
  46. 46.
    Stimson WH (1974) Quantitation of a new serum a 2-macroglobulin in malignant disease, steroid treatment, pregnancy and normal subjects. J Endocrinol 61:3Google Scholar
  47. 47.
    Thomson AW, Home CHW (1980) Biological and clinical significance of pregnancy-associated a 2-glycoprotein (a 2-PAG) — a review. Invest Cell Pathol 3:295PubMedGoogle Scholar
  48. 48.
    Bohn H, Winckler W (1976) Isolierung und Charakterisierung des schwangerschafts-as-soziierten Alpha-2-Glykoproteins (Alpha-2-PAG). Blut 33:377PubMedCrossRefGoogle Scholar
  49. 49.
    Bohn H, Bauer HW (1979) Schwangerschafts-assoziiertes a 2-Glykoprotein (a 2-PAG): Bedeutung seiner Bestimmung bei malignen Erkrankungen. Laboratoriumsblätter 29:119Google Scholar
  50. 50.
    Than GN, Csaba JF, Szabo DG, Paal M, Ambrus M, Baytai C (1975) In vitro suppression effect of pregnancy-associated a 2-glycoprotein on the lymphocyte blastogenic response. JRCS 3:309Google Scholar
  51. 51.
    Damber MG, Schoultz BV, Stigbrand T, Tärnvik A (1975) Inhibition of the mixed lymphocyte reaction by the pregnancy zone protein. Lett 58:29Google Scholar
  52. 52.
    Stimson WH (1976) Studies on the immunosuppressive properties of a pregnancy-associated a 2-macroglobulin. Clin Exp Immunol 25:199PubMedGoogle Scholar
  53. 53.
    Persellin RH, Rhodes J (1981) Inhibition of human monocyte Fc receptor and HLA-DR antigen expression by pregnancy alpha-2-glycoprotein. Clin Exp Immunol 46:350PubMedGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt 1986

Authors and Affiliations

  • D. Brackertz
    • 1
  1. 1.Abt. RheumatologieSt. Vincenz- und Elisabeth-Hospital MainzMainzGermany

Personalised recommendations